New policy trends are emerging in the field of traditional Chinese medicine biotechnology

New policies have been recently introduced by relevant national departments in the field of traditional Chinese medicine (TCM) biotechnology, aiming to promote the standardized and innovative development of the industry. The policies emphasize the protection and rational development of TCM resources, encouraging enterprises to increase their investment in R&D in the areas of TCM cultivation and processing technologies. Additionally, more policy support, including tax incentives and financial subsidies, has been provided for the transformation of innovative achievements in TCM biotechnology enterprises. This shift in policy direction has brought new development opportunities for TCM biotechnology enterprises, prompting them to focus more on technological innovation and talent cultivation to meet the new requirements of industry development.